Antiviral and anti-inflammatory therapies in COVID-19

被引：11

作者：

Szekanecz Zoltan ^{[1
]}

Bogos Krisztina ^{[2
]}

Constantin Tamas ^{[3
]}

Fullesdi Bela ^{[4
]}

Muller Veronika ^{[5
]}

Rakoczi Eva ^{[1
]}

Varkonyi Istvan ^{[6
]}

Valyi-Nagy Istvan ^{[7
]}

机构：

[1] Debreceni Egyet, Altalanos Orvostud Kar, Belgyogyaszati Klin, Reumatol, Debrecen, Hungary

[2] Orszagos Koranyi Pulmonol Int, Budapest, Hungary

[3] Semmelweis Egyet, Altalanos Orvostud Kar, Gyermekgyogyaszati Klin 2, Budapest, Hungary

[4] Debreceni Egyet, Altalanos Orvostud Kar, Aneszteziol & Intenz Terapias Klin, Debrecen, Hungary

[5] Semmelweis Egyet, Altalanos Orvostud Kar, Pulmonol Klin, Budapest, Hungary

[6] Debreceni Egyet, Altalanos Orvostud Kar, Infektol Klin, Debrecen, Hungary

[7] Del Pesti Ctr Korhaz, Orszagos Hematol & Infektol Int, Budapest, Hungary

来源：

ORVOSI HETILAP | 2021年 / 162卷 / 17期

关键词：

novel coronavirus infection (COVID-19); coronavirus; cytokine storm; antiviral treatment; cytokine in-hibition treatment; corticosteroid; interleukin-6; inhibition; Janus kinase inhibition; intravenous immunoglobulin; TOCILIZUMAB; MULTICENTER;

D O I：

10.1556/650.2021.32230

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The novel coronavirus infection (COVID-19) places a heavy burden on the health care system and our society. There are three major stages in the disease that fundamentally determine treatment approaches. Phases I?IIA require primarily antiviral treatment. In phases IIB?III, anti-inflammatory treatment is needed accompanied by intensive and supportive care. This recommendation applies only to pharmacotherapy and summarizes the therapeutic options based on the available evidence. It also includes a proposed treatment algorithm.

引用

页码：643 / 651

页数：9

共 50 条

[31] Anti-inflammatory therapy for COVID-19 infection: the case for colchicine
Reyes, Aaron Z.
Hu, Kelly A.
Teperman, Jacob
Wampler Muskardin, Theresa L.
Tardif, Jean-Claude
Shah, Binita
Pillinger, Michael H.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (05) : 550 - 557
[32] Immunomodulatory and anti-inflammatory potential of crocin in COVID-19 treatment
Ghasemnejad-Berenji, Morteza
JOURNAL OF FOOD BIOCHEMISTRY, 2021, 45 (05)
[33] Antiviral and anti-inflammatory drugs to combat COVID-19: Effects on cardiac ion channels and risk of ventricular arrhythmias
Cubeddu, Luigi X.
de la Rosa, Daisy
Ameruoso, Michele
BIOIMPACTS, 2022, 12 (01) : 9 - 20
[34] Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches
Choi, Hojun
Shin, Eui-Cheol
BMB REPORTS, 2022, 55 (01) : 11 - 19
[35] COVID-19 treatment by anti-coagulation: anti-thrombotic and anti-inflammatory?
Paar, V.
Wernly, B.
Zhou, Z.
Motloch, L. J.
Hoppe, U. C.
Egle, A.
Lichtenauer, M.
WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S217 - S217
[36] Use of Antiviral Agents and other Therapies for COVID-19
Blaskovich, Mark A. T.
Verderosa, Anthony D.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 44 (01) : 118 - 129
[37] Prostaglandins and non-steroidal anti-inflammatory drugs in Covid-19
Al-Kuraishy, Hayder M.
Al-Gareeb, Ali, I
Al-Maiahy, Thabat J.
Alexiou, Athanasios
Mukerjee, Nobendu
Batiha, Gaber El-Saber
BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2022, 40 (04) : 3305 - 3325
[38] Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19
Moutsopoulos, Haralampos M.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (09) : 1253 - +
[39] Anti-inflammatory effects of GLP-1 in patients with COVID-19
Sazgarnejad, Saharnaz
Yazdanpanah, Niloufar
Rezaei, Nima
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (03) : 373 - 381
[40] BAY 11-7082: An Anti-inflammatory Drug for COVID-19
Nemati, Mohadeseh
Pouya, Fahima Danesh
Asl, Elmira Roshani
Rasmi, Yousef
SUDAN JOURNAL OF MEDICAL SCIENCES, 2023, 18 (01): : 117 - 120

← 1 2 3 4 5 →